Lo Steven

CIK 00015019594 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001501959

Recent Transactions

50 trades

Tax Payment
Vaxart, Inc.$VXRT
Common Stock
2026-03-24$0.69/sh−126,028→ 2,485,606 total
Tax Payment
Vaxart, Inc.$VXRT
Common Stock
2026-03-18$0.63/sh−22,425→ 2,611,634 total
Award
Vaxart, Inc.$VXRT
Stock Option (right to buy)
2026-03-16+1,543,000→ 1,543,000 total
Award
Vaxart, Inc.$VXRT
Common Stock
2026-03-16+846,500→ 2,634,059 total
Award
Vaxart, Inc.$VXRT
Common Stock
2025-12-04+151,351→ 1,841,712 total
Tax Payment
Vaxart, Inc.$VXRT
Common Stock
2025-12-04$0.37/sh−54,153→ 1,787,559 total
Purchase
Vaxart, Inc.$VXRT
Common Stock
2025-05-19$0.49/sh+100,000→ 100,000 total
Award
Vaxart, Inc.$VXRT
Stock Option (right to buy)
2025-03-24+2,108,000→ 2,108,000 total
Award
Vaxart, Inc.$VXRT
Common Stock
2025-03-24+1,405,000→ 1,632,638 total
Tax Payment
Vaxart, Inc.$VXRT
Common Stock
2025-03-18$0.57/sh−22,362→ 227,638 total
Award
Vaxart, Inc.$VXRT
Stock Option (right to buy)
2024-03-18+1,000,000→ 1,000,000 total
Award
Vaxart, Inc.$VXRT
Common Stock
2024-03-18+250,000→ 250,000 total
Sale
Zosano Pharma Corp
Common Stock
2022-06-06$0.71/sh−442→ 13,163 total
Sale
Zosano Pharma Corp
Common Stock
2022-03-31$0.21/sh−23,633→ 460,709 total
Award
Zosano Pharma Corp
Stock Option (Right to Buy)
2021-10-15+237,500→ 237,500 total
Award
Zosano Pharma Corp
Common Stock
2021-10-15+118,750→ 484,342 total
Sale
Zosano Pharma Corp
Common Stock
2021-06-04$0.81/sh−13,158→ 365,592 total
Award
Zosano Pharma Corp
Stock Option (Right to Buy)
2021-03-30+465,000→ 465,000 total
Award
Zosano Pharma Corp
Common Stock
2021-03-30+232,500→ 378,750 total
Award
Zosano Pharma Corp
Stock Option (Right to Buy)
2021-03-18+450,000→ 450,000 total
Award
Zosano Pharma Corp
Common Stock
2020-06-25+146,250→ 146,250 total
Award
Zosano Pharma Corp
Stock Option (Right to Buy)
2020-06-03+292,500→ 292,500 total
Award
Zosano Pharma Corp
Stock Option (Right to Buy)
2019-10-21+450,000→ 450,000 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-07-22$10.04/sh−1,852→ 19,557 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2019-02-06+36,300→ 36,300 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-01-22$24.91/sh−2,114→ 21,409 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2018-07-20$51.85/sh−1,839→ 23,523 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2018-02-11+33,000→ 33,000 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2018-01-22$92.85/sh−1,858→ 25,362 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2017-07-20$94.90/sh−1,990→ 27,220 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2017-02-16+31,500→ 31,500 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2017-01-20$33.24/sh−2,290→ 29,210 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2016-10-14+31,500→ 31,500 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2016-05-25+30,000→ 30,000 total
Exercise/Conversion
CORCEPT THERAPEUTICS INC$CORT
Stock option
2015-11-16$3.51/sh+286,040→ 0 total
Exercise/Conversion
CORCEPT THERAPEUTICS INC$CORT
Common stock
2015-11-16$3.51/sh+113,960→ 113,960 total
Exercise/Conversion
CORCEPT THERAPEUTICS INC$CORT
Stock option
2015-11-16$2.70/sh+33,333→ 0 total
Exercise/Conversion
CORCEPT THERAPEUTICS INC$CORT
Common stock
2015-11-16$2.08/sh+64,583→ 497,916 total
Exercise/Conversion
CORCEPT THERAPEUTICS INC$CORT
Stock option
2015-11-16$3.51/sh+113,960→ 0 total
Exercise/Conversion
CORCEPT THERAPEUTICS INC$CORT
Stock option
2015-11-16$1.92/sh+87,500→ 0 total
Exercise/Conversion
CORCEPT THERAPEUTICS INC$CORT
Common stock
2015-11-16$3.51/sh+286,040→ 400,000 total
Exercise/Conversion
CORCEPT THERAPEUTICS INC$CORT
Common stock
2015-11-16$2.70/sh+33,333→ 433,333 total
Exercise/Conversion
CORCEPT THERAPEUTICS INC$CORT
Common stock
2015-11-16$1.92/sh+87,500→ 585,416 total
Exercise/Conversion
CORCEPT THERAPEUTICS INC$CORT
Stock option
2015-11-16$2.08/sh+64,583→ 0 total
Sale
CORCEPT THERAPEUTICS INC$CORT
Common stock
2015-11-02$4.00/sh−12,500→ 0 total
Exercise/Conversion
CORCEPT THERAPEUTICS INC$CORT
Common stock
2015-10-26$3.29/sh+12,500→ 12,500 total
Exercise/Conversion
CORCEPT THERAPEUTICS INC$CORT
Stock option
2015-10-26$3.29/sh+12,500→ 0 total
Sale
CORCEPT THERAPEUTICS INC$CORT
Common stock
2015-10-13$3.82/sh−53,033→ 0 total
Sale
CORCEPT THERAPEUTICS INC$CORT
Common stock
2015-10-07$4.00/sh−5,300→ 53,033 total
Sale
CORCEPT THERAPEUTICS INC$CORT
Common stock
2015-10-06$3.76/sh−50,000→ 58,333 total

Companies

Recent Filings

Address

C/O VAXART, INC. 170 HARBOR WAY, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov